论著
ENGLISH ABSTRACT
五个结核分枝杆菌重组蛋白及其组合物的细胞免疫评价
闫宇涵
李马超
刘海灿
肖彤洋
李娜
楼永良
万康林
作者及单位信息
·
DOI: 10.3760/cma.j.cn112150-20191119-00872
Cellular immunity evaluation of five mycobacterium tuberculosis recombinant proteins and their compositions
Yan Yuhan
Li Machao
Liu Haican
Xiao Tongyang
Li Na
Lou Yongliang
Wan Kanglin
Authors Info & Affiliations
Yan Yuhan
School of Laboratory Medicine and Life Science, Wenzhou Medical University, Wenzhou 325035, China
Li Machao
State Key Laboratory for Infection Diseases Prevention and Control/National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China
Liu Haican
State Key Laboratory for Infection Diseases Prevention and Control/National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China
Xiao Tongyang
Guangdong Key Lab for Diagnosis & Treatment of Emerging Infectious Diseases, Shenzhen Third People's Hospital, Southern University of Science and Technology, Guangzhou 518112, China
Li Na
State Key Laboratory for Infection Diseases Prevention and Control/National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China
Lou Yongliang
School of Laboratory Medicine and Life Science, Wenzhou Medical University, Wenzhou 325035, China
Wan Kanglin
School of Laboratory Medicine and Life Science, Wenzhou Medical University, Wenzhou 325035, China
·
DOI: 10.3760/cma.j.cn112150-20191119-00872
899
110
0
0
0
0
PDF下载
APP内阅读
摘要

目的对5个结核分枝杆菌重组蛋白及其组合物的细胞免疫进行评价。

方法88份新鲜肝素抗凝人群外周静脉血液,其中42份来自北京市昌平区结核病防治所就诊的结核病患者,46份健康志愿者由中国疾病预防控制中心传染病所提供,均为接种过卡介苗(BCG)且没有结核暴露史和任何临床症状体征的健康人。以结核分枝杆菌标准菌株H37Rv DNA为模板,PCR扩增选取的5个重组蛋白Rv3874、Rv3875、Rv2031c、Rv1411c和Rv3418c的完整编码基因;通过基因重组和蛋白纯化技术,分别克隆、表达和纯化5个重组蛋白作为刺激物,采用效应T细胞酶联免疫斑点试验(ELISPOT)对人群进行细胞免疫检测。

结果成功克隆、表达和纯化了Rv3874、Rv3875、Rv2031c、Rv1411c和Rv3418c重组蛋白;灵敏度分别为50.00%、71.43%、69.04%、73.81%和76.19%;特异度分别为86.96%、76.09%、71.74%、39.13%和36.96%。阳性预测值、阴性预测值、曲线下面积及约登指数分别为52.46%~77.78%、62.96%~74.47%、0.511~0.754和0.129~0.475。除Rv1411c和Rv3418c外,Rv3874、Rv3875和Rv2031c在结核病患者中检测到的斑点形成细胞数均高于健康志愿者,差异均具有统计学意义( P值均<0.001)。在5个重组蛋白所构成的26种组合物中,灵敏度为80.95%~95.24%,特异度为68.89%~24.44%。随着组合物中重组蛋白个数的增加其灵敏度逐渐增加,但特异度随之下降。

结论结核分枝杆菌重组蛋白Rv3874、Rv3875和Rv2031c刺激T细胞产生免疫应答的能力较强,具有一定的抗原性。而Rv1411c和Rv3418c单独用作诊断抗原的效能并不理想,与多组分抗原联合构成的组合物具有一定应用价值。

分枝杆菌,结核;重组蛋白质类;免疫,细胞;组合物;实验研究
ABSTRACT

ObjectiveThe cellular immunity of 5 Mycobacterium tuberculosis recombinant proteins and their compositions was evaluated.

MethodA total of 88 fresh venous blood from peripheral heparin anticoagulant population, 42 of which were from tuberculosis patients treated by The Tuberculosis Prevention and Treatment Center of Changping District, Beijing, and 46 of healthy volunteers were provided by the Infection Diseases of Chinese Center for Disease Control and Prevention. Healthy volunteers without a history of tuberculosis exposure and any clinical signs and symptoms. Using the Mycobacterium tuberculosis standard strain H37Rv DNA as a template, complete genes of the selected 5 recombinant proteins Rv3874, Rv3875, Rv2031c, Rv1411c and Rv3418c by PCR amplified; 5 recombinant proteins were cloned, expressed and purified as stimulants by genetic recombination and protein purification techniques, and the effector T cell enzyme-linked immunospot assay (ELISPOT) was used to detect cellular immunity in the population.

ResultsThe recombinant proteins Rv3874, Rv3875, Rv2031c, Rv1411c and Rv3418c were successfully cloned, expressed and purified; And the sensitivities were 50.00%, 71.43%, 69.04%, 73.81% and 76.19%, and the specificities were 86.96%, 76.09%, 71.74%, 39.13% and 36.96%. In addition, the positive predictive value, negative predictive value, area under the curve and Youden index were 52.46% to 77.78%, 62.96% to 74.47%, 0.511 to 0.754 and 0.129 to 0.475, respectively. Except for Rv1411c and Rv3418c, the number of spot-forming cell (SFC) detected by Rv3874, Rv3875 and Rv2031c in tuberculosis patients was higher than healthy volunteers, and the differences were statistically significant ( P<0.001). Among the 26 compositions composed of 5 recombinant proteins, the sensitivity was 80.95% to 95.24%, and the specificity was 68.89% to 24.44%. As the number of recombinant proteins in the composition increases, the sensitivity gradually increased, but the specificity decreased.

ConclusionThe recombinant proteins of Mycobacterium tuberculosis Rv3874, Rv3875 and Rv2031c have strong ability to stimulate T cells to produce immune response, and have certain antigenicity. The efficacy of Rv1411c and Rv3418c alone as diagnostic antigens is not ideal, and the composition composed of multi-component antigens has certain application value. This article provides experimental evidence for the immune diagnosis of tuberculosis and the preparation of new anti-tuberculosis vaccines.

Mycobacterium tuberculosis;Recombinant proteins;Immunity cellular;Compositions;Experimental study
Wan Kanglin, Email: nc.defcdabcinilgnaknaw
引用本文

闫宇涵,李马超,刘海灿,等. 五个结核分枝杆菌重组蛋白及其组合物的细胞免疫评价[J]. 中华预防医学杂志,2020,54(05):539-545.

DOI:10.3760/cma.j.cn112150-20191119-00872

PERMISSIONS

Request permissions for this article from CCC.

评价本文
*以上评分为匿名评价
结核病主要是因呼吸道感染了结核分枝杆菌而引起的一种慢性传染病,目前仍然是严重威胁全球人类生命健康和社会经济发展的公共危机。据2019年世界卫生组织发布的全球结核报告显示,2018年结核病患者约1 000万例,其中死于结核病的例数约有124万 [ 1 ]。虽然结核病发病率呈下降趋势,但由于耐药结核特别是耐多药和广泛耐药结核病的流行增加,全世界面临的挑战仍相当严峻。防控结核病的关键是要及早发现及时治疗,虽然一些分枝杆菌特异抗原已经用于结核病的免疫学诊断 [ 2 , 3 ],但灵敏度或特异度都存在着较大差异,因此找到更多的免疫优势抗原对提高免疫诊断技术以及用于新型抗结核疫苗的制备具有相当重要的价值。本研究基于检索免疫学表位数据库结合生物信息学对结核分枝杆菌蛋白质组的抗原表位预测分析,筛选出具有特异性T细胞表位的抗原多肽的结核分枝杆菌蛋白的基础上,从中选择了Rv3874、Rv3875、Rv2031c、Rv1411c和与Rv3418c 5个重组蛋白对人群进行细胞免疫的评价。根据Lalvani等 [ 4 ],本研究采用了酶联免疫斑点试验(enzyme-linked immunospot assay,ELISPOT)对5个结核分枝杆菌重组蛋白及其组合物进行细胞免疫的初步评价 [ 5 , 6 , 7 ],为筛选得到更多的结核分枝杆菌优势抗原以及进一步研究有效的免疫抗原组合奠定基础。
试读结束,您可以通过登录机构账户或个人账户后获取全文阅读权限。
参考文献
[1]
World Health Organization. Global tuberculosis report 2019[EB/OL]. [ 2019-12-31]. https://www.who.int/tb/publications/global_report/en/.
返回引文位置Google Scholar
百度学术
万方数据
[2]
Shakibamehr N , Mosavari N , Babaie M ,et al. Evaluate the efficiency of Antigen 60 (A60) protein from BCG strain of Mycobacterium bovis as a diagnostic antigen[J]. Int J Mycobacteriol, 2016,5Suppl 1:S226-S227. DOI: 10.1016/j.ijmyco.2016.10.022 .
返回引文位置Google Scholar
百度学术
万方数据
[3]
Bekmurzayeva A , Sypabekova M , Kanayeva D . Tuberculosis diagnosis using immunodominant, secreted antigens of Mycobacterium tuberculosis[J]. Tuberculosis(Edinb), 2013,93(4):381-388. DOI: 10.1016/j.tube.2013.03.003 .
返回引文位置Google Scholar
百度学术
万方数据
[4]
Lalvani A , Pathan AA , McShane H ,et al. Rapid detection of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells[J]. Am J Respir Crit Care Med, 2001,163(4):824-828. DOI: 10.1164/ajrccm.163.4.2009100 .
返回引文位置Google Scholar
百度学术
万方数据
[5]
李晓琴肖彤洋李马超,. 结核分枝杆菌Dnak和MPT83蛋白的抗原性评价[J]. 中华微生物学和免疫学杂志, 2019,39(2):106-113. DOI: 10.3760/cma.j.issn.0254-5101.2019.02.005 .
返回引文位置Google Scholar
百度学术
万方数据
[6]
Wang X , Chen S , Xu Y ,et al. Identification and evaluation of the novel immunodominant antigen Rv2351c from Mycobacterium tuberculosis[J]. Emerg Microbes Infect, 2017,6(6):e48. DOI: 10.1038/emi.2017.34 .
返回引文位置Google Scholar
百度学术
万方数据
[7]
Xiao TY , Liu HC , Li XQ ,et al. Immunological Evaluation of a Novel Mycobacterium tuberculosis Antigen Rv0674[J]. Biomed Environ Sci, 2019,32(6):427-437. DOI: 10.3967/bes2019.056 .
返回引文位置Google Scholar
百度学术
万方数据
[8]
Deng Y , Liu Y , Li Y ,et al. Isolation measures and protection awareness are significant for latent tuberculosis infection: a cross-sectional study based on T-SPOT. TB among health care workers in China[J]. Epidemiol Infect, 2019,147:e120. DOI: 10.1017/S0950268818002777 .
返回引文位置Google Scholar
百度学术
万方数据
[9]
余述凤王学中. T-SPOT在肺结核中的诊断价值[J]. 临床肺科杂志, 2015,20(7):1237-1240.
返回引文位置Google Scholar
百度学术
万方数据
[10]
Andersen P . TB vaccines: progress and problems[J]. Trends Immunol, 2001,22(3):160-168. DOI: 10.1016/s1471-4906(01)01865-8 .
返回引文位置Google Scholar
百度学术
万方数据
[11]
Qiu Y , Wang Y , Lin N ,et al. Multicenter clinical evaluation of three commercial reagent kits based on the interferon-gamma release assay for the rapid diagnosis of tuberculosis in China[J]. Int J Infect Dis, 2015,40:108-112. DOI: 10.1016/j.ijid.2015.09.004 .
返回引文位置Google Scholar
百度学术
万方数据
[12]
Tan S , Lin N , Huang M ,et al. CTL immunogenicity of Rv3615c antigen and diagnostic performances of an ESAT-6/CFP-10/Rv3615c antigen cocktail for Mycobacterium tuberculosis infection[J]. Tuberculosis(Edinb), 2017,107:5-12. DOI: 10.1016/j.tube.2017.07.011 .
返回引文位置Google Scholar
百度学术
万方数据
[13]
Millington KA , Fortune SM , Low J ,et al. Rv3615c is a highly immunodominant RD1 (Region of Difference 1)-dependent secreted antigen specific for Mycobacterium tuberculosis infection[J]. Proc Natl Acad Sci U S A, 2011,108(14):5730-5735. DOI: 10.1073/pnas.1015153108 .
返回引文位置Google Scholar
百度学术
万方数据
[14]
Li J , Shen J , Lao S ,et al. Mycobacterium tuberculosis Rv3615c is a highly immunodominant antigen and specifically induces potent Th1-type immune responses in tuberculosis pleurisy[J]. Clin Sci (Lond), 2017,131(15):1859-1876. DOI: 10.1042/CS20170205 .
返回引文位置Google Scholar
百度学术
万方数据
[15]
Pai M , Denkinger CM , Kik SV ,et al. Gamma interferon release assays for detection of Mycobacterium tuberculosis infection[J]. Clin Microbiol Rev, 2014,27(1):3-20. DOI: 10.1128/CMR.00034-13 .
返回引文位置Google Scholar
百度学术
万方数据
[16]
van Pinxteren LA , Ravn P , Agger EM ,et al. Diagnosis of tuberculosis based on the two specific antigens ESAT-6 and CFP10[J]. Clin Diagn Lab Immunol, 2000,7(2):155-160. DOI: 10.1128/cdli.7.2.155-160.2000 .
返回引文位置Google Scholar
百度学术
万方数据
[17]
Yousefi Avarvand A , Khademi F , Tafaghodi M ,et al. The roles of latency-associated antigens in tuberculosis vaccines[J]. Indian J Tuberc, 2019,66(4):487-491. DOI: 10.1016/j.ijtb.2019.04.012 .
返回引文位置Google Scholar
百度学术
万方数据
[18]
Wieczorek AE , Troudt JL , Knabenbauer P ,et al. HspX vaccination and role in virulence in the guinea pig model of tuberculosis[J]. Pathog Dis, 2014,71(3):315-325. DOI: 10.1111/2049-632X.12147 .
返回引文位置Google Scholar
百度学术
万方数据
[19]
Aravindhan V , Christy AJ , Roy S ,et al. Mycobacterium tuberculosis groE promoter controls the expression of the bicistronic groESL1 operon and shows differential regulation under stre ss conditions [J]. FEMS Microbiol Lett, 2009,292(1):42-49. DOI: 10.1111/j.1574-6968.2008.01465.x .
返回引文位置Google Scholar
百度学术
万方数据
[20]
Drage MG , Tsai HC , Pecora ND ,et al. Mycobacterium tuberculosis lipoprotein LprG (Rv1411c) binds triacylated glycolipid agonists of Toll-like receptor 2[J]. Nat Struct Mol Biol, 2010,17(9):1088-1095. DOI: 10.1038/nsmb.1869 .
返回引文位置Google Scholar
百度学术
万方数据
[21]
López-Ramos JE , Macías-Segura N , Cuevas-Cordoba B ,et al. Improvement in the Diagnosis of Tuberculosis Combining Mycobacterium Tuberculosis Immunodominant Peptides and Serum Host Biomarkers[J]. Arch Med Res, 2018,49(3):147-153.e1. DOI: 10.1016/j.arcmed.2018.07.003 .
返回引文位置Google Scholar
百度学术
万方数据
[22]
Wu X , Yang Y , Zhang J ,et al. Comparison of antibody responses to seventeen antigens from Mycobacterium tuberculosis[J]. Clin Chim Acta, 2010,411(19-20):1520-1528. DOI: 10.1016/j.cca.2010.06.014 .
返回引文位置Google Scholar
百度学术
万方数据
[23]
Lyashchenko K , Colangeli R , Houde M ,et al. Heterogeneous antibody responses in tuberculosis[J]. Infect Immun, 1998,66(8):3936-3940.
返回引文位置Google Scholar
百度学术
万方数据
备注信息
A
万康林,Email: nc.defcdabcinilgnaknaw
B

闫宇涵,李马超,刘海灿,等.五个结核分枝杆菌重组蛋白及其组合物的细胞免疫评价[J].中华预防医学杂志, 2020, 54(5): 539-545. DOI: 10.3760/cma.j.cn112150-20191119-00872.

C
所有作者均声明不存在利益冲突
D
国家科技重大专项 (2018ZX10731301-002)
评论 (0条)
注册
登录
时间排序
暂无评论,发表第一条评论抢沙发
MedAI助手(体验版)
文档即答
智问智答
机器翻译
回答内容由人工智能生成,我社无法保证其准确性和完整性,该生成内容不代表我们的态度或观点,仅供参考。
生成快照
文献快照

你好,我可以帮助您更好的了解本文,请向我提问您关注的问题。

0/2000

《中华医学会杂志社用户协议》 | 《隐私政策》

《SparkDesk 用户协议》 | 《SparkDesk 隐私政策》

网信算备340104764864601230055号 | 网信算备340104726288401230013号

技术支持:

历史对话
本文全部
还没有聊天记录
设置
模式
纯净模式沉浸模式
字号